Periostin

Periostin, osteoblast specific factor
Identifiers
Symbols POSTN ; OSF-2; OSF2; PDLPOSTN; PN; periostin
External IDs OMIM: 608777 MGI: 1926321 HomoloGene: 4730 GeneCards: POSTN Gene
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 10631 50706
Ensembl ENSG00000133110 ENSMUSG00000027750
UniProt Q15063 Q62009
RefSeq (mRNA) NM_001135934 NM_001198765
RefSeq (protein) NP_001129406 NP_001185694
Location (UCSC) Chr 13:
37.56 – 37.6 Mb		 Chr 3:
54.36 – 54.39 Mb
PubMed search

Periostin (POSTN, PN, or osteoblast-specific factor OSF-2) is a protein that in humans is encoded by the POSTN gene.[1][2] Periostin functions as a ligand for alpha-V/beta-3 and alpha-V/beta-5 integrins to support adhesion and migration of epithelial cells.[3]

Periostin is a gla domain vitamin K dependent factor.[4]

Function

Periostin is a secreted extracellular matrix protein that was originally identified in cells from the mesenchymal lineage (osteoblasts, osteoblast-derived cells, the periodontal ligament, and periosteum). It has been associated with the epithelial-mesenchymal transition in cancer and with the differentiation of mesenchyme in the developing heart.[5] This protein shares a homology with fasciclin I, a secreted cell adhesion molecule found in insects.

In many cancers, periostin binds to integrins on cancer cells, activating the Akt/PKB- and FAK-mediated signaling pathways. This leads to increased cell survival, invasion, angiogenesis, metastasis, and the epithelial-mesenchymal transition.[6]

In humans and mice, periostin undergoes alternative splicing in its C-terminal region, resulting in specific isoforms that can be observed in a broad range of cancers such as pancreatic, colon, and breast cancer.[5]

While periostin plays a wide variety of roles in tissue development along with disease, its function in tissue remodeling as a response to injury is a common underlying role in these different mechanisms. Periostin is transiently upregulated during cell fate changes, whether they are related to alterations in physiology or to pathological changes. It influences extracellular matrix restructuring, tissue remodeling, and the epithelial-mesenchymal transition, all of which can be related to tissue healing, development, and disease. Thus, it functions as a mediator, balancing appropriate and inappropriate responses to tissue damage.[7]

Clinical significance

In valvular heart disease

Periostin plays a critical role in the development of cardiac valves and in degenerative valvular heart disease. While periostin usually is localized to the subendothelial layer in healthy heart valves, its levels are highly increased in infiltrated inflammatory cells and myofibroblasts in angiogenic areas in atherosclerotic and rheumatic valvular heart disease in humans. Periostin has also been shown to increase the secretion of matrix metalloproteinase from valvular intestinal cells, endothelial cells, and macrophages. It is thought that periostin plays a role in cardiac valve complex degeneration by inducing both angiogenesis and matrix metalloproteinase production.[8]

In tissue regeneration and healing

As a matricellular protein, periostin is also important for tissue regeneration. In healthy human skin, periostin is expressed at basal levels and is expressed in the epidermis and hair follicles along with fibronectin and laminin γ2.[7][9] Periostin is involved in wound healing, helping for the wound to heal faster than when periostin is not present in cells. This delay in wound closure is also associated with a delay in re-epithelialization and a reduction in the proliferation of keratinocytes.[9] Periostin localizes to the extracellular compartment of cells during tissue remodeling associated with wound repair. It may also promote injury closure by facilitating the activation, differentiation, and contraction of fibroblasts. However, the increase in periostin expression associated with tissue regeneration post-injury is transient, starting a few days post-injury, peaking after seven days post-injury, and decreasing afterwards.[7]

In asthma

Periostin is associated with asthma, a fact that is exploited by the experimental asthma medication lebrikizumab.[10]

In cancer

Periostin over-expression was reported in several types of cancer, most frequently in the environment of tumor cells.[3][11] Recent evidence shows that periostin is a component of the extracellular matrix expressed by fibroblasts in normal tissues and stroma of primary tumor. The metastatic colony formation requires the induction of periostin in the foreign stroma by the infiltrating cancer cells. Periostin production is upregulated in lung fibroblasts by either TGF-β2 or TGF-β3, the latter being secreted by infiltrating cancer stem cells (in MMTV-PyMT mouse breast cancer model) [12]

Periostin has been shown to be highly upregulated in glioblastomas (grade IV gliomas) compared to the normal brain. In gliomas, periostin expression levels correlate directly with tumor grade and recurrence, and inversely with survival.[13] It has been shown that glioma stem cells in glioblastomas secrete periostin, which recruits M2 tumor-associated macrophages from peripheral blood to the tumor environment via αvβ3 integrin signaling. These M2 TAMs differentiate from monocytes once they enter the tumor tissue. Through this recruitment mechanism, periostin supports tumor progression, as M2 tumor-associated macrophages are tumor-supportive and immunosuppressive. In this environment, periostin functions as a chemoattractant, promoting both migration and invasion of macrophages and monocytes into glioblastomas in a dose-dependent manner.[14] Clinically, periostin-associated gene signatures, which are predominated by secreted and matrix proteins, correspond to patient prognosis and malignancy. Given its features related to glioblastoma progression, periostin is a marker of glioma malignancy as well as recurrence of tumors, making it a possible target for therapy that continues to be studied and explored.[13]

Table: Periostin expression in various cancer cell lines.[15]

Cell line Origin POSTN/ACTB1
U2OS Osteosarcoma 3.5±1.7
LB96 Ewing Sarcoma 0
LB23-1 Rhabdomyosarcoma 0.1±0.1
HeLa Cervical cancer 3.0±0.4
PA-1 Ovarian teratocarcinoma 1.4±0.1
LB37-1 NSCLC
LB85 SCLC 3.4±0.2
LB92 SCLC 0.6±0.2
LB1047 Renal cell carcinoma 0.8±0.2
BB64 Renal cell carcinoma 0.08±0.01
LB108 Colorectal cancer 0
MCF7 Breast Cancer 0
Hs578T Breast Cancer 3693±86
Panc-1 Pancreatic carcinoma 0
Capan-1 Pancreatic carcinoma 0
Huh-7 Hepatocarcinoma 0.3±0.07
LB831 Bladder carcinoma 1748±74
MZGC3 Stomach cancer 0
A172 Glioblastoma 45±4
MZ2 Melanoma 2.3±0.7
LB39 Melanoma 0.5±0.03
LB2586-7 Melanoma 3.4±0.3
LB2201-3 Melanoma 4.2±0.4
A375 Melanoma 4.7±1.2

1 (cDNA POSTN/cDNA ACTB) × 104

References

  1. ↑ Takeshita S, Kikuno R, Tezuka K, Amann E (Aug 1993). "Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I". The Biochemical Journal. 294 294 (1): 271–8. doi:10.1042/bj2940271. PMC 1134594. PMID 8363580.
  2. ↑ "Entrez Gene: POSTN periostin, osteoblast specific factor".
  3. 1 2 Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD (Sep 2002). "Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility". Cancer Research 62 (18): 5358–64. PMID 12235007.
  4. ↑ Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J (Jun 2008). "Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells". The Journal of Biological Chemistry 283 (26): 17991–8001. doi:10.1074/jbc.M708029200. PMID 18450759.
  5. 1 2 Hoersch S, Andrade-Navarro MA (2010). "Periostin shows increased evolutionary plasticity in its alternatively spliced region". BMC Evolutionary Biology 10: 30. doi:10.1186/1471-2148-10-30. PMID 20109226.
  6. ↑ Morra L, Moch H (Nov 2011). "Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update". Virchows Archiv 459 (5): 465–75. doi:10.1007/s00428-011-1151-5. PMID 21997759.
  7. 1 2 3 Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, Arron JR, Holweg CT, Kudo A (Apr 2014). "The role of periostin in tissue remodeling across health and disease". Cellular and Molecular Life Sciences 71 (7): 1279–88. doi:10.1007/s00018-013-1494-y. PMID 24146092.
  8. ↑ Hakuno D, Kimura N, Yoshioka M, Mukai M, Kimura T, Okada Y, Yozu R, Shukunami C, Hiraki Y, Kudo A, Ogawa S, Fukuda K (Jul 2010). "Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents". The Journal of Clinical Investigation 120 (7): 2292–306. doi:10.1172/JCI40973. PMID 20551517.
  9. 1 2 Braun N, Sen K, Alscher MD, Fritz P, Kimmel M, Morelle J, Goffin E, Jörres A, Wüthrich RP, Cohen CD, Segerer S. "Periostin: a matricellular protein involved in peritoneal injury during peritoneal dialysis". Peritoneal Dialysis International 33 (5): 515–28. doi:10.3747/pdi.2010.00259. PMID 23378472.
  10. ↑ Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG (Sep 2011). "Lebrikizumab treatment in adults with asthma". The New England Journal of Medicine 365 (12): 1088–98. doi:10.1056/NEJMoa1106469. PMID 21812663.
  11. ↑ Contié S, Voorzanger-Rousselot N, Litvin J, Clézardin P, Garnero P (Jan 2011). "Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases". International Journal of Cancer. Journal International Du Cancer 128 (2): 352–60. doi:10.1002/ijc.25591. PMID 20715172.
  12. ↑ Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr HA, Delaloye JF, Huelsken J (Jan 2012). "Interactions between cancer stem cells and their niche govern metastatic colonization". Nature 481 (7379): 85–9. doi:10.1038/nature10694. PMID 22158103.
  13. 1 2 Mikheev AM, Mikheeva SA, Trister AD, Tokita MJ, Emerson SN, Parada CA, Born DE, Carnemolla B, Frankel S, Kim DH, Oxford RG, Kosai Y, Tozer-Fink KR, Manning TC, Silber JR, Rostomily RC (Aug 2014). "Periostin is a novel therapeutic target that predicts and regulates glioma malignancy". Neuro-Oncology 17: 372–82. doi:10.1093/neuonc/nou161. PMID 25140038.
  14. ↑ Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, Rich JN, Bao S (Feb 2015). "Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth". Nature Cell Biology 17 (2): 170–82. doi:10.1038/ncb3090. PMID 25580734.
  15. ↑ Tilman G, Mattiussi M, Brasseur F, van Baren N, Decottignies A (2007). "Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells". Molecular Cancer 6 (80): 80. doi:10.1186/1476-4598-6-80. PMC 2222651. PMID 18086302.

Further reading

This article is issued from Wikipedia - version of the Thursday, March 24, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.